Image

Global Label-Free Array Systems Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Label-Free Array Systems Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Label-Free Array Systems Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1.32 Billion
Diagram Market Size (Forecast Year) USD 2.15 Billion
Diagram CAGR %

Major Markets Players

  • General Electric
  • Agilent Technologies
  • Danaher
  • F. Hoffmann La Roche Ltd
  • BioRad Laboratories

Global Label-Free Array Systems Market, By Technique (Surface Plasmon Resonance, Microcantilever, Scanning Kelvin Nanoprobe, Enthalpy Array, Atomic Force Microscopy, Bio Layer Interferometry, Cellular Dielectric Spectroscopy, Electrochemical Impedance Spectroscopy, Quartz Crystal Microbalance Interference-based Technique, Ellipsometry Technique, Others), Application (Drug Discovery, Biomolecular Interactions, Protein Interface Analysis, Antibody Characterization and Development, Protein Complex and Cascade Analysis, Detection of Disease Biomarkers, Others), End-User (CROs, Academic and Research Institutes, Agricultural Research Institutes, Pharmaceutical and Biotechnology Industries) – Industry Trends and Forecast to 2030.

Label-Free Array Systems Market

Label-Free Array Systems Market Analysis and Size

Label-free array systems are known to inhibit the expression of certain genes that is different from conventional medicine. In past years, innovative new oligonucleotides have been developed that are capable of targeting specific genes and treat chronic diseases.

Data Bridge Market Research analyses that the global label-free array systems market which was USD 1.32 billion in 2022, is expected to reach USD 2.15 billion by 2030, and is expected to undergo a CAGR of 7.55% during the forecast period 2023-2030. This indicates that the market value. “Drug Discovery” dominates the application segment of the label-free array systems market owing to an increase in the number of researches for drug discovery. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Label-Free Array Systems Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Technique (Surface Plasmon Resonance, Microcantilever, Scanning Kelvin Nanoprobe, Enthalpy Array, Atomic Force Microscopy, Bio Layer Interferometry, Cellular Dielectric Spectroscopy, Electrochemical Impedance Spectroscopy, Quartz Crystal Microbalance Interference-based Technique, Ellipsometry Technique, Others), Application (Drug Discovery, Biomolecular Interactions, Protein Interface Analysis, Antibody Characterization and Development, Protein Complex and Cascade Analysis, Detection of Disease Biomarkers, Others), End-User (CROs, Academic and Research Institutes, Agricultural Research Institutes, Pharmaceutical and Biotechnology Industries)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

General Electric (U.S.), Agilent Technologies, Inc. (U.S.) Danaher (U.S.); F. Hoffmann-La Roche Ltd (Switzerland); Bio-Rad Laboratories, Inc. (U.S.); PerkinElmer Inc. (U.S.); Attana (Sweden); BiOptix Analytical LLC (U.S.); Eppendorf AG (Germany); Molecular Devices, LLC (U.S.); Berthold Technologies GmbH and Co. KG (Germany); Arrayjet (U.K.); GeSiM; and Plexera Bioscience (U.S.)

Market Opportunities

  • Launch of innovative and technologically advanced products to meet the needs of customers
  • Increase in the prevalence of infectious diseases
  • Increase in the number of mergers and acquisitions among manufacturers

Market Definition

Label-free systems are defined as a biotechnological identification technology based on identification of various molecules based on their biophysical properties, molecular charge to accurately isolate the presence of molecular presence. This technology helps in real-time detection of molecular events, and can provide greater levels of information due to its utilization of only proteins and ligands.           

Global Label-Free Array Systems Market Dynamics

Drivers

  • Growing Demand in Drug Discovery and Development

Label-free array systems are used extensively in the pharmaceutical and biotechnology industries for drug discovery, target identification, and drug screening. Their ability to provide real-time, quantitative data without the need for labels or tags makes them invaluable in these applications.

  • Increasing Adoption in Proteomics and Biomarker Discovery

Label-free array systems are crucial for proteomics research and biomarker discovery. They enable researchers to study protein-protein interactions, protein-ligand binding, and protein quantification in complex biological samples. The need for more accurate and high-throughput techniques in proteomics has driven the adoption of label-free technologies.

  • Rising Focus on Personalized Medicine 

The trend toward personalized medicine, where treatments are tailored to individual patients, has increased the demand for label-free array systems. These systems play a key role in characterizing patient-specific biomarkers and assessing drug responses, which are essential for developing personalized therapeutic approaches.

  • Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Rising Adoption in Clinical Diagnostics

Label-free array systems have significant potential in clinical diagnostics, including the detection of biomarkers associated with various diseases such as cancer, cardiovascular diseases, and infectious diseases. The increasing demand for early and accurate disease diagnosis presents a substantial opportunity for label-free array systems to be integrated into clinical laboratories and point-of-care settings.

  • Expanding Applications in Drug Repurposing

With the growing interest in drug repurposing (finding new uses for existing drugs), label-free array systems can play a crucial role in identifying the interactions between drugs and biological targets. This application can lead to the discovery of new therapeutic indications for existing medications, reducing development timelines and costs.

Restraints/ Challenges

  • High Cost of Implementation

Label-Free Array Systems often involve a substantial initial investment in equipment, consumables, and maintenance. This cost can be a significant barrier for smaller research laboratories and institutions, limiting their ability to adopt this technology.

  • Complexity of Data Analysis

While label-free technologies provide valuable data, the analysis of the generated data can be complex and require specialized expertise. Researchers may face challenges in interpreting the results, leading to potential delays in experiments or misinterpretation of findings.

  • Limited Sensitivity for Low-Abundance Targets

Label-free array systems may have limitations in detecting low-abundance biomolecules or interactions, as their sensitivity can vary depending on the technology used. This can be a restraint when studying rare biomarkers or weak binding interactions.

  • Competition from Established Technologies

Label-free array systems face competition from well-established technologies such as traditional enzyme-linked immunosorbent assays (ELISA) and fluorescent-based assays. Researchers and laboratories may be hesitant to transition to label-free technologies, especially when they have existing workflows based on these established methods.

This global label-free array systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global label-free array systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In March 2023, Charles River Laboratories purchased SAMDI Tech. The acquisition follows more than a decade of expansion made possible by SAMDI Tech's occupancy of the University Technology Park (UTP) incubator at Illinois Institute of Technology
  • In May 2022, Sartorius unveiled the new Octet SF3, the company's 1st Surface Plasmon Resonance solution. Due to the system's low base-line noise and drift, large injection volumes, and novel injection techniques, users may generate better kinetics and the affinity data short time period

Global Label-Free Array Systems Market Scope

The global label-free array systems market is segmented on the basis of technique, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

  • Surface Plasmon Resonance
  • Microcantilever
  • Scanning Kelvin Nanoprobe
  • Enthalpy Array
  • Atomic Force Microscopy
  • Bio Layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Electrochemical Impedance Spectroscopy
  • Quartz Crystal Microbalance Interference-Based technique
  • Ellipsometry technique
  • Others

Application

  • Drug Discovery
  • Biomolecular Interactions
  • Protein Interface Analysis
  • Antibody Characterization and Development
  • Protein Complex and Cascade Analysis
  • Detection of Disease Biomarkers
  • Others

End-User

  • CROs
  • Academic and Research Institutes
  • Agricultural Research Institutes
  • Pharmaceutical and Biotechnology Industries

Global Label-Free Array Systems Market Analysis/Insights

The global label-free array systems market is analyzed and market size insights and trends are provided by country, technique, application and end-user as referenced above.

The countries covered in the label-free array systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global label-free array systems market due to rise in the surgical procedures, increase in the R&D activities initiated by government and rise in the geriatric population in this region.   

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2023 to 2030 due to the surge in demand for advanced technologies in label-free array systems.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global label-free array systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for label-free array systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the label-free array systems market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Label-Free Array Systems Market Share Analysis

The global label-free array systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global label-free array systems market.

Some of the major players operating in the global label-free array systems market are:

  • General Electric (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Danaher (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Attana (Sweden)
  • BiOptix Analytical LLC (U.S.)
  • Eppendorf AG (Germany)
  • Molecular Devices, LLC (U.S.)
  • Berthold Technologies GmbH and Co. KG (Germany)
  • Arrayjet (U.K.)
  • GeSiM
  • Plexera Bioscience (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The label-free array systems market size will be worth USD 2.15 billion by 2030.
The growth rate of the label-free array systems market is 7.55% in the forecast period by 2030.
Growing demand in drug discovery and development, increasing adoption in proteomics and biomarker discovery & rising focus on personalized medicine are the growth drivers of the label-free array systems market.
Technique, application and end-user are the factors on which the label-free array systems market research is based.
Major companies in the label-free array systems market are General Electric (U.S.), Agilent Technologies, Inc. (U.S.) Danaher (U.S.); F. Hoffmann-La Roche Ltd (Switzerland); Bio-Rad Laboratories, Inc. (U.S.); PerkinElmer Inc. (U.S.); Attana (Sweden); BiOptix Analytical LLC (U.S.); Eppendorf AG (Germany); Molecular Devices, LLC (U.S.); Berthold Technologies GmbH and Co. KG (Germany); Arrayjet (U.K.); GeSiM; and Plexera Bioscience (U.S.)
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials